+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Can the U.S. Food and Drug Administration act against global frauds? The extraterritorial effect of Food and Drug Administration sanctions after Small v. United States



Can the U.S. Food and Drug Administration act against global frauds? The extraterritorial effect of Food and Drug Administration sanctions after Small v. United States



Food and Drug Law Journal 60(3): 347-360




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048433207

Download citation: RISBibTeXText

PMID: 16304742


Related references

Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. Notice. Federal Register 64(79): 20312-3, 1999

United States Food and Drug Administration seeks global regulatory regime. Cmaj 183(12): E777-E778, 2011

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. PharmacoTherapy 28(8): 992-998, 2008

Regulatory science: A special update from the United States Food and Drug Administration: Preclinical issues and status of investigation of botanical drug products in the United States. Toxicology Letters (Shannon) 111(3): 199-202, 2000

Oncology drug development: United States Food and Drug Administration perspective. Critical Reviews in Oncology/Hematology 42(2): 137-143, 2002

United States Food and Drug Administration requirements for approval of generic drug products. Journal of Clinical Psychiatry 62(Suppl. 5): 4-9; Discussion 23-4, 2001

The United States Food and Drug Administration's approach to training international suppliers in food safety and security. HortTechnology 16(4): 566-569, 2006

U.S. Food and Drug Administration drug approval: slow advances in obstetric care in the United States. Obstetrics and Gynecology 115(4): 825-833, 2010

Adverse drug event reports at the United States Food And Drug Administration Center for Veterinary Medicine. Journal of the American Veterinary Medical Association 225(4): 533-536, 2004

Update on regulatory review intervals for ophthalmic new drug applications at the United States Food and Drug Administration. American Journal of Ophthalmology 130(5): 664-665, 2000

United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets. Clinical Cancer Research 10(4): 1212-1218, 2004

The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy. International Journal of Health Services 4(1): 95, 1974

Regulatory use of computational toxicology tools and databases at the United States Food and Drug Administration's Office of Food Additive Safety. Expert Opinion on Drug Metabolism and Toxicology 6(7): 793-796, 2010

Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database. PharmacoTherapy 38(8): 785-793, 2018

Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system. Current Opinion in Anaesthesiology 23(3): 423-427, 2010